Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle M Merrigan

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
International Journal of Antimicrobial Agents|March 24, 2009
New approach to the management of Clostridium difficile infection: colonisation with non-toxigenic C. difficile during daily ampicillin or ceftriaxone administrationMichelle M Merrigan, Susan P Sambol, Stuart Johnson, et al.
The Journal of Infectious Diseases|December 16, 2003
Prevention of fatal Clostridium difficile-associated disease during continuous administration of clindamycin in hamstersMichelle M Merrigan, Susan P Sambol, Stuart Johnson, et al.
The Journal of Infectious Diseases|November 26, 2002
Colonization for the prevention of Clostridium difficile disease in hamstersSusan P Sambol, Michelle M Merrigan, Janet K Tang, et al.
Journal of Clinical Microbiology|April 19, 2003
International typing study of toxin A-negative, toxin B-positive Clostridium difficile variantsStuart Johnson, Susan P Sambol, Jon S Brazier, et al.
Anaerobe|April 29, 2014
International typing study of Clostridium difficileCarl E Manzo, Michelle M Merrigan, Stuart Johnson, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|April 6, 2006
Genotypic and phenotypic analysis of Clostridium difficile correlated with previous antibiotic exposureMatthew H Samore, Lata Venkataraman, Paola C DeGirolami, et al.
Journal of Clinical Medicine|January 5, 2021
The Relative Role of Toxins A and B in the Virulence of <i>Clotridioides difficile</i>Andrew M Skinner, S Tyler Phillips, Michelle M Merrigan, et al.
Plos One|November 23, 2013
Surface-layer protein A (SlpA) is a major contributor to host-cell adherence of Clostridium difficileMichelle M Merrigan, Anilrudh Venugopal, Jennifer L Roxas, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
International Journal of Antimicrobial Agents|March 24, 2009
New approach to the management of Clostridium difficile infection: colonisation with non-toxigenic C. difficile during daily ampicillin or ceftriaxone administrationMichelle M Merrigan, Susan P Sambol, Stuart Johnson, et al.
The Journal of Infectious Diseases|December 16, 2003
Prevention of fatal Clostridium difficile-associated disease during continuous administration of clindamycin in hamstersMichelle M Merrigan, Susan P Sambol, Stuart Johnson, et al.
The Journal of Infectious Diseases|November 26, 2002
Colonization for the prevention of Clostridium difficile disease in hamstersSusan P Sambol, Michelle M Merrigan, Janet K Tang, et al.
Journal of Clinical Microbiology|April 19, 2003
International typing study of toxin A-negative, toxin B-positive Clostridium difficile variantsStuart Johnson, Susan P Sambol, Jon S Brazier, et al.
Anaerobe|April 29, 2014
International typing study of Clostridium difficileCarl E Manzo, Michelle M Merrigan, Stuart Johnson, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|April 6, 2006
Genotypic and phenotypic analysis of Clostridium difficile correlated with previous antibiotic exposureMatthew H Samore, Lata Venkataraman, Paola C DeGirolami, et al.
Journal of Clinical Medicine|January 5, 2021
The Relative Role of Toxins A and B in the Virulence of <i>Clotridioides difficile</i>Andrew M Skinner, S Tyler Phillips, Michelle M Merrigan, et al.
Plos One|November 23, 2013
Surface-layer protein A (SlpA) is a major contributor to host-cell adherence of Clostridium difficileMichelle M Merrigan, Anilrudh Venugopal, Jennifer L Roxas, et al.
Pageof 1